This years 2026 ASCO Gastrointestinal Cancers Symposium was packed with practice-shaping data across colorectal and upper ...
The U.S. Food and Drug Administration (FDA) has approved Guardant360 CDx as a companion diagnostic to identify patients with ...
MedPage Today on MSN
Targeted duo wins again in BRAF-mutant colorectal cancer
Response rates with encorafenib-cetuximab plus FOLFIRI similar to combo plus modified FOLF ...
Novel treatment allowed patients with colorectal cancer to successfully continue taking their cancer treatment with improved quality of life Acne-like skin rash is a common side effect from colorectal ...
A small group of patients with treatment-refractory, HER2-positive metastatic colorectal cancer achieved a remarkable response with a common targeted therapy regimen used to treat HER2-positive breast ...
Philip Felshman was given only a few years to live. The otherwise healthy New Yorker described the news as a "big shock." He'd been happily working for 33 years as a service manager, enjoying time ...
A vast number and variety of remedies are steadily joining the treatment pipeline for colorectal cancer. High incidence of the disease, unmet clinical needs, and huge commercial potential are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results